SCHEMBL827779

SCHEMBL827779

CN(C)c1ccnc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.51
NCF1 P14598 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.47
CHKA P35790 1/20 0.45
HTR1A P08908 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
CHEK1 O14757 1/20 0.44
NEK2 P51955 1/20 0.44
LIMK1 P53667 1/20 0.44
DYRK1A Q13627 1/20 0.44
CLK4 Q9HAZ1 1/20 0.44
SLC40A1 Q9NP59 1/20 0.43
HTR2C P28335 1/20 0.43
HTR2B P41595 1/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
EP300 Q09472 1/20 0.42
KAT2B Q92831 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL269369 0.86 KDM4E (0.52) HRH3NCF1CHEK1NEK2LIMK1
SCHEMBL6530619 0.81 CHKA (0.68) HRH3NCF1LOXL2CHKAHSD17B10
SCHEMBL15453232 0.80 HRH3 (0.56) HRH3NCF1LOXL2CHKAHTR1A
SCHEMBL14359324 0.79 HRH3 (0.60) HRH3NCF1LOXL2HTR1AADRA1D
SCHEMBL28792044 0.78 HRH3 (0.48) HRH3NCF1LOXL2CHKAHTR1A
SCHEMBL2937021 0.78 HRH3 (0.45) HRH3NCF1LOXL2CHKAHTR2C
SCHEMBL10403777 0.78 HRH3 (0.51) HRH3NCF1LOXL2CHKAHTR1A
SCHEMBL16596266 0.77 HRH3 (0.64) HRH3NCF1LOXL2CHKAHTR1A
Methane SCHEMBL8954604 0.77 HRH3 (0.47) HRH3NCF1LOXL2CHKAHTR1A
SCHEMBL30307401 0.77 HRH3 (0.53) HRH3NCF1LOXL2CHKAADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115710215-B Phenylethynyl substituted benzenes and heterocycles for the treatment of cancer and uses thereof 肯塔基大学研究基金会 2024-06-04 CN claimed
EP-4087889-B1 STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF PROMERUS LLC (US) 2024-03-06 EP claimed
US-11697701-B2 Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof PROMERUS, LLC (US) 2023-07-11 US claimed
US-11692056-B2 Stable polycycloolefin polymer and inorganic nanoparticle compositions as optical materials PROMERUS, LLC (US) 2023-07-04 US claimed
CN-114938648-B Stable bulk polymerized polycycloolefin compositions as three-dimensional printing materials and methods of making same 住友电木株式会社 2023-06-30 CN claimed
CN-115710215-A Phenylethynyl substituted benzenes and heterocycles useful in the treatment of cancer and uses thereof 肯塔基大学研究基金会 2023-02-24 CN claimed
EP-4087889-A1 STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF Promerus, LLC (US) 2022-11-16 EP claimed
EP-2586893-B1 COPPER PLATING BATH AND CORRESPONDING METHOD ROHM & HAAS ELECT MAT (US) 2022-09-21 EP claimed
CN-114938648-A Stable bulk polymerized polycyclic olefin compositions as three-dimensional printing materials and methods of making same 普罗米鲁斯有限责任公司 2022-08-23 CN claimed
US-11299573-B2 Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof PROMERUS LLC (US) 2022-04-12 US claimed
CN-114144450-A Stable polycycloolefin polymers and inorganic nanocomposites as optical materials 普罗米鲁斯有限责任公司 2022-03-04 CN claimed
CN-113490527-A Bicyclic derivatives 瑞士伊兰科动物保健有限公司 2021-10-08 CN claimed
US-20210221931-A1 STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF PROMERUS, LLC (US) 2021-07-22 US claimed
WO-2021142402-A1 STABLE MASS POLYMERIZABLE POLYCYCLOOLEFIN COMPOSITIONS AS 3D PRINTING MATERIALS AND A METHOD OF FABRICATION THEREOF PROMERUS, LLC (US) 2021-07-15 WO claimed
WO-2021016503-A1 STABLE POLYCYCLOOLEFIN POLYMER AND INORGANIC NANOPARTICLE COMPOSITIONS AS OPTICAL MATERIALS PROMERUS, LLC (US) 2021-01-28 WO claimed
US-20210024685-A1 STABLE POLYCYCLOOLEFIN POLYMER AND INORGANIC NANOPARTICLE COMPOSITIONS AS OPTICAL MATERIALS PROMERUS, LLC (US) 2021-01-28 US claimed
CN-103103584-A Plating bath and method ROHM & HAAS ELECT MAT 2013-05-15 CN claimed
EP-2586893-A2 Copper plating bath and method Rohm and Haas Electronic Materials LLC (US) 2013-05-01 EP claimed
US-12037431-B2 Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof PROMERUS, LLC (US) 2024-07-16 US disclosed
US-4160837-A ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1979-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11697701-B2 Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof RRP15, PPOX, NONO HRH3 3703/4885NCF1 2660/4885LOXL2 655/4885
US-12037431-B2 Stable mass polymerizable polycycloolefin compositions as 3D printing materials and a method of fabrication thereof RRP15, PPOX, NONO HRH3 3703/4885NCF1 2660/4885LOXL2 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.